Sandoz Secures Renewable Energy for 90% of European Operations

Sandoz, a pharmaceutical firm headquartered in Switzerland and specializing in generics and biosimilars, has formalized a decade-long virtual Power Purchase Agreement (PPA) with Elawan Energy. The agreement will support the creation of solar energy infrastructure in Spain, aimed at supplying the majority of the company’s electricity needs across its European operations.

The initiative will result in the construction of solar plants with a combined output capacity of 150 megawatts. Once these facilities are active, they are projected to meet nearly 90% of the electricity requirements for Sandoz’s European sites, which account for the largest portion of its global energy consumption.

This move aligns with Sandoz’s long-term environmental strategy. The company has pledged to reach net zero emissions by 2050 and, as of 2024, has committed to establishing science-based targets for carbon reduction. These targets are expected to be submitted to the Science Based Targets initiative (SBTi) by January 2026 for validation.

Glenn Gerecke, Chief Manufacturing and Supply Officer at Sandoz, highlighted the company’s dedication to sustainability, describing it as a core operational principle. He noted that the collaboration with Elawan Energy represents a significant step toward reducing emissions, with the solar projects expected to substantially lower the environmental impact of Sandoz’s European facilities.

The solar installations will be located in Castilla y León, Spain. Elawan Energy stated that the agreement will enable several of its key development projects to proceed to commercial launch.

Diego Garcia, who oversees Revenue Management and PPAs at Elawan Energy, expressed pride in the partnership, emphasizing that the collaboration supports Elawan’s broader mission to assist corporate clients in transitioning to renewable energy solutions.